Loading clinical trials...
Loading clinical trials...
The purpose of this research is to determine the extent to which oculomotor function accurately detects THC-impairment, if cannabis use experience impacts this detection threshold, and to examine how ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Johns Hopkins University
Collaborators
NCT05877196 · Mild Cognitive Impairment, Alzheimer Disease, and more
NCT06575751 · Cannabis Use Disorder
NCT06784908 · HIV, Depression, and more
NCT06223672 · Cognitive Decline, Cognitive Impairment
NCT07101380 · Mild Cognitive Impairment (MCI)
Johns Hopkins Behavioral Pharmacology Research Unit
Baltimore, Maryland
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions